Effect of Edaravone on Neurological Symptoms in Real-World Patients With Acute Ischemic Stroke

Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016

(2018)   NEW ENGLAND JOURNAL OF MEDICINE

Edaravone with and without .6 Mg/Kg Alteplase within 4.5 Hours after Ischemic Stroke: A Prospective Cohort Study (PROTECT4.5)

(2017) Takenori Yamaguchi et al.   Journal of Stroke & Cerebrovascular Diseases

Edaravone with and without .6 Mg/Kg Alteplase within 4.5 Hours after Ischemic Stroke: A Prospective Cohort Study (PROTECT4.5)

(2017) Takenori Yamaguchi et al.   Journal of Stroke & Cerebrovascular Diseases

Clinical Trials in Acute Ischemic Stroke

(2014) Kiyoshi Kikuchi et al.   CNS DRUGS

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack

(2014) Walter N. Kernan et al.   STROKE

Does Modern Ischemic Stroke Therapy in a Large Community-based Dedicated Stroke Center Improve Clinical Outcomes? A Two-Year Retrospective Study

(2013) Matthew H. Berlet et al.   Journal of Stroke & Cerebrovascular Diseases

Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010

(2013) Valery L Feigin et al.   LANCET

Edaravone for acute stroke: Meta-analyses of data from randomized controlled trials

(2013) Jie Yang et al.   Developmental Neurorehabilitation

Efficacy of the Free Radical Scavenger, Edaravone, for Motor Palsy of Acute Lacunar Infarction

(2009) Yasuyuki Ohta et al.   INTERNAL MEDICINE

Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008

(2008)   CEREBROVASCULAR DISEASES